Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rory B. Riggs currently holds 14,916,640 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rory B. Riggs has been a net seller of ITCI stock. They have purchased $6.9M and sold $253.6M worth of shares.
Rory B. Riggs's most recent insider trade was on Jan 29, 2026, when they sold 333,333 shares at $1.50 per share.
Rory B. Riggs serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 179 insider transactions totaling $260.6M over their tenure at the company.
Rory B. Riggs holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 23 years and currently hold a stake valued at $0.
Rory B. Riggs has shown a selling trading pattern, with $6.9M in total purchases and $253.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rory B. Riggs was on May 22, 2023, when they sold $57.4M worth of RPRX shares. This transaction involved 1,750,000 shares at $32.82 per share.
Rory B. Riggs currently owns 14,916,640 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rory B. Riggs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rory B. Riggs has 179 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..
Set alerts for Rory B. Riggs and 40,000+ other insiders.